Yong Liu Selected Research

Yong Liu Research Topics

Disease

334	Neoplasms (Cancer) 12/2022 - 01/2002
75	Infections 08/2022 - 09/2002
71	Inflammation (Inflammations) 01/2022 - 01/2002
56	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
51	Fibrosis (Cirrhosis) 07/2022 - 04/2008
46	Hypoxia (Hypoxemia) 07/2022 - 09/2007
41	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 01/2013
37	Ischemia 01/2022 - 07/2003
36	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2002
35	Brain Ischemia (Cerebral Ischemia) 01/2021 - 11/2002
32	Insulin Resistance 02/2021 - 11/2007
31	Squamous Cell Carcinoma of Head and Neck 02/2022 - 11/2010
29	Carcinogenesis 07/2022 - 06/2006
29	Hypertension (High Blood Pressure) 02/2022 - 07/2007
29	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2007
28	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 03/2004
28	Obesity 04/2022 - 02/2008
26	Carcinoma (Carcinomatosis) 10/2022 - 04/2002
26	Lung Neoplasms (Lung Cancer) 10/2021 - 12/2003
25	Glioma (Gliomas) 12/2022 - 10/2002
25	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2003
25	Wounds and Injuries (Trauma) 01/2022 - 09/2009
23	Lymphatic Metastasis 01/2020 - 09/2002
22	Atherosclerosis 06/2022 - 04/2005
22	Pain (Aches) 01/2022 - 04/2007
22	Heart Failure 01/2022 - 03/2012
21	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 09/2002
20	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2015
19	COVID-19 02/2022 - 01/2020
19	Cognitive Dysfunction 01/2022 - 01/2014
19	Brain Injuries (Brain Injury) 01/2021 - 02/2006
18	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 09/2009
18	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 11/2009
18	Status Epilepticus (Complex Partial Status Epilepticus) 02/2022 - 02/2007
18	ST Elevation Myocardial Infarction 01/2022 - 11/2010
18	Chronic Renal Insufficiency 01/2022 - 09/2013
18	Myocardial Infarction 01/2022 - 07/2006
17	Schizophrenia (Dementia Praecox) 10/2022 - 08/2009
17	Stroke (Strokes) 01/2022 - 02/2006
17	Chronic Hepatitis B 01/2022 - 02/2011
16	Diabetes Mellitus 02/2022 - 04/2009
16	Infarction (Infarctions) 01/2021 - 12/2004
16	Nasopharyngeal Carcinoma 03/2018 - 09/2009
15	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 04/2015
15	Reperfusion Injury 05/2022 - 06/2007
15	Melanoma (Melanoma, Malignant) 05/2022 - 03/2002
15	Necrosis 01/2021 - 04/2007
14	Pancreatitis 05/2022 - 03/2011
14	Disease Progression 04/2022 - 06/2014
14	Body Weight (Weight, Body) 01/2022 - 09/2006
14	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 07/2003
13	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2003
13	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 05/2006

Drug/Important Bio-Agent (IBA)

129	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2005
93	Biomarkers (Surrogate Marker)IBA 08/2022 - 05/2006
57	Pharmaceutical PreparationsIBA 06/2022 - 06/2004
52	MicroRNAs (MicroRNA)IBA 08/2022 - 09/2009
48	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
46	Biological ProductsIBA 01/2022 - 03/2002
45	CytokinesIBA 01/2022 - 01/2002
32	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2003
31	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2006
28	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 07/2002
27	Long Noncoding RNAIBA 01/2022 - 03/2014
25	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2011
23	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2002
23	EnzymesIBA 03/2022 - 09/2009
21	Indicators and Reagents (Reagents)IBA 12/2021 - 04/2009
21	Insulin (Novolin)FDA Link 10/2021 - 11/2007
20	Retinaldehyde (Retinal)IBA 11/2022 - 07/2009
20	Phosphotransferases (Kinase)IBA 10/2022 - 09/2003
20	AntigensIBA 01/2022 - 01/2002
18	C-Reactive ProteinIBA 01/2022 - 05/2007
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2003
17	Oxygen (Dioxygen)IBA 08/2022 - 05/2014
17	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 02/2007
17	Bromodeoxyuridine (BrdU)IBA 01/2021 - 10/2005
17	Therapeutic UsesIBA 01/2021 - 04/2007
16	LigandsIBA 01/2022 - 03/2002
16	LipidsIBA 01/2022 - 11/2007
15	Peptides (Polypeptides)IBA 12/2022 - 02/2006
15	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 06/2007
15	VaccinesIBA 02/2022 - 11/2006
15	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2007
14	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2006
14	CholesterolIBA 06/2022 - 05/2007
14	CreatinineIBA 03/2022 - 01/2013
14	oxidized low density lipoproteinIBA 01/2022 - 09/2005
13	salicylhydroxamic acid (SHAM)IBA 10/2022 - 11/2002
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 06/2010
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2002

Therapy/Procedure

147	Therapeutics 06/2022 - 11/2003
52	Percutaneous Coronary Intervention 01/2022 - 05/2012
40	Radiotherapy 07/2022 - 07/2002
37	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
24	Transplantation 01/2022 - 07/2009
21	Immunotherapy 10/2022 - 01/2002
14	Stents 04/2021 - 11/2009
14	Decompression 01/2020 - 09/2009
13	Length of Stay 06/2021 - 01/2012